13 December 2021
Roquefort Investments plc
("Roquefort Investments" or the "Company")
Results of General Meeting
Roquefort Investments (LSE:ROQ), the London listed investment company established to acquire businesses focused on early-stage opportunities in the medical biotechnology sector , is pleased to announce that at the Company's General Meeting held earlier today, all resolutions proposed were duly passed.
The resolutions were put to shareholders via a poll, the results of which were as follows:
Resolution |
Poll Results |
|||||
For |
Against |
Abstain |
Discretionary |
Total |
||
1 |
Shares |
1,800,000 |
- |
- |
- |
1,800,000 |
% |
100% |
- |
- |
- |
100% |
|
2 |
Shares |
1,800,000 |
- |
- |
- |
1,800,000 |
% |
100% |
- |
- |
- |
100% |
|
3 |
Shares |
1,800,000 |
- |
- |
- |
1,800,000 |
% |
100% |
- |
- |
- |
100% |
|
4 |
Shares |
1,800,000 |
- |
- |
- |
1,800,000 |
% |
100% |
- |
- |
- |
100% |
The total number of ordinary shares in issue on 9 December 2021, the deadline for casting votes by proxy in advance of the General Meeting, was 36,900,000 shares. 4.88% of voting capital was instructed in respect of the resolutions put to the Genaral Meeting.
Roquefort Investments plc |
|
Stephen West (Chairman) |
+44 (0)20 3290 9339
|
Buchanan (Public Relations) Ben Romney / Jamie Hooper
Optiva Securities Limited (Broker) |
+44 (0)20 7466 5000 |
Christian Dennis |
+44 (0)20 3411 1881 |
For further information on Roquefort Investments, please visit www.roquefortinvest.com and @roquefortinvest on Twitter.
LEI: 254900P4SISIWOR9RH34